NASDAQ:QDEL - Quidel Stock Price, Forecast & News

Quidel trades on the NASDAQ under the ticker symbol "QDEL."

Quidel Co. (NASDAQ:QDEL) posted its earnings results on Wednesday, February, 12th. The company reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.18. The firm earned $152.20 million during the quarter, compared to analysts' expectations of $148 million. Quidel had a return on equity of 22.71% and a net margin of 13.63%. The firm's revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.80 earnings per share. View Quidel's Earnings History.

Quidel is scheduled to release their next quarterly earnings announcement on Wednesday, May 13th 2020. View Earnings Estimates for Quidel.

Quidel issued an update on its fourth quarter 2019 After-Hours earnings guidance on Thursday, January, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $151-152 million, compared to the consensus revenue estimate of $139.17 million.

4 brokers have issued 12-month price objectives for Quidel's stock. Their forecasts range from $75.00 to $92.00. On average, they anticipate Quidel's share price to reach $79.75 in the next year. This suggests a possible upside of 3.4% from the stock's current price. View Analyst Price Targets for Quidel.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quidel in the last year. There are currently 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Quidel.

Media stories about QDEL stock have trended somewhat negative this week, according to InfoTrie. The research firm ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Quidel earned a media sentiment score of -1.7 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Quidel.

Quidel saw a increase in short interest in the month of February. As of February 14th, there was short interest totalling 2,230,000 shares, an increase of 16.1% from the January 30th total of 1,920,000 shares. Based on an average daily volume of 216,400 shares, the short-interest ratio is presently 10.3 days. Approximately 6.1% of the company's shares are short sold. View Quidel's Current Options Chain.

Some companies that are related to Quidel include Align Technology (ALGN), Cooper Companies (COO), West Pharmaceutical Services (WST), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Cerus (CERS), Anika Therapeutics (ANIK), Antares Pharma (ATRS), OraSure Technologies (OSUR) and Utah Medical Products (UTMD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Quidel investors own include Netflix (NFLX), Intel (INTC), Alibaba Group (BABA), Adobe (ADBE), NVIDIA (NVDA), Gilead Sciences (GILD), Mastercard (MA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Energy Transfer LP Unit (ET).

Quidel's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Fred Alger Management LLC (4.01%), ArrowMark Colorado Holdings LLC (2.87%), State Street Corp (2.09%), New York State Common Retirement Fund (1.80%), Eagle Asset Management Inc. (1.39%) and Geode Capital Management LLC (1.20%). Company insiders that own Quidel stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Karen Gibson, Kenneth F Buechler, Mary Lake Ph D Polan, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Thomas D Brown and Werner Kroll. View Institutional Ownership Trends for Quidel.

QDEL stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace North America L.P., Marshall Wace LLP, Goldman Sachs Group Inc., Chicago Equity Partners LLC, Gabelli Funds LLC, Chartwell Investment Partners LLC, Rothschild & Co. Asset Management US Inc. and Investment Management of Virginia LLC. Company insiders that have sold Quidel company stock in the last year include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Karen Gibson, Kenneth F Buechler, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar and Werner Kroll. View Insider Buying and Selling for Quidel.

QDEL stock was bought by a variety of institutional investors in the last quarter, including Bridger Management LLC, Public Employees Retirement Association of Colorado, BNP PARIBAS ASSET MANAGEMENT Holding S.A., Royce & Associates LP, ArrowMark Colorado Holdings LLC, Prudential Financial Inc., Fred Alger Management LLC and Barclays PLC. View Insider Buying and Selling for Quidel.

Shares of QDEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of QDEL stock can currently be purchased for approximately $77.10.

Quidel has a market capitalization of $3.23 billion and generates $534.89 million in revenue each year. The company earns $72.92 million in net income (profit) each year or $2.73 on an earnings per share basis. Quidel employs 1,250 workers across the globe.View Additional Information About Quidel.

The official website for Quidel is http://www.quidel.com/.

Quidel's mailing address is 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121. The company can be reached via phone at 858-552-1100 or via email at [email protected]